Fig. 2From: COVID-19 vaccination is associated with enhanced efficacy of anti-PD-(L)1 immunotherapy in advanced NSCLC patients: a real-world studyThe influence of fibrinogen, NLR or COVID-19 vaccination on PFS or OS. A The ROC curves for fibrinogen; B The effect of fibrinogen on progression-free survival (PFS); C The effect of COVID-19 vaccination on PFS; D The ROC curves for NLR. E The effect of NLR on overall survival (OS); F The effect of COVID-19 vaccination on OSBack to article page